A study on the safety and effectiveness of tolvaptan for patients with fluid retention after valvular surgery
Phase 4
- Conditions
- Patients received cardiac surgery for cardiac valvular disease
- Registration Number
- JPRN-UMIN000009957
- Lead Sponsor
- Osaka University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1.Patients with hypersensitivity to study drug 2.Anuric patients 3.Patients with hypernatremia 4.Female patients who are pregnant, possibly pregnant, or lactating, or who plan to become pregnant 5.Malignant tumor 6.Patients with serious hepatic disorder or Serious Renal failure 7.Patients otherwise judged by the investigator or subinvestigator to be inappropriate for inclusion in the study
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method